Hinge Health HNGE
- Market cap
- $9.3B
- PE
- 88.2×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 12.9×
- EV/EBIT
- 95.4×
- Revenue, 12 months
- $720.1M
- +50% on a year ago
- Net margin
- 15.1%
- Free cash flow yield
- 3.1%
Hinge Health trades at 88.2× trailing earnings. Revenue was $720.1M over the last twelve months, up 50% on a year earlier with a 15% net margin.
Charts
Financials
| Income statement | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| $82.7M | $89.8M | $100.6M | $117.3M | $123.8M+50% | $139.1M+55% | $154.2M+53% | $170.7M+46% | $182.3M+47% | $212.8M+53% | |
| Cost of revenue | $24.8M | $23.2M | $21.4M | $21.2M | $23.6M−5% | $41.3M+78% | $28M+31% | $26.7M+26% | $28.1M+19% | $28.9M−30% |
| Gross profit | $57.9M | $66.6M | $79.3M | $96.1M | $100.2M+73% | $97.8M+47% | $126.2M+59% | $144M+50% | $154.2M+54% | $183.9M+88% |
| R&D | $29.8M | $24.9M | $23.8M | $22.4M | $23.5M−21% | $280M+1023% | $31.9M+34% | $32.8M+46% | $30.3M+29% | $34.1M−88% |
| SG&A | $59.6M | $59.2M | $59.3M | $52.8M | $63.6M+7% | $398.5M+573% | $100.4M+69% | $84M+59% | $91.8M+44% | $109.5M−73% |
| −$31.4M | −$17.6M | −$3.8M | $20.9M | $13.1M | −$580.7M+3209% | −$6.1M+59% | $27.3M+30% | $32.1M+144% | $40.4M | |
| Pre-tax income | −$26.3M | −$12.6M | $1.4M | $26.2M | $18.1M | −$576M+4484% | −$1.6M | $32.2M+23% | $35.9M+98% | $44.4M |
| $158K | $361K | $1.1M | −$951K | $998K+532% | −$326K | $206K−81% | $122K | $814K−18% | $740K | |
| Net income | −$26.5M | −$12.9M | $341K | $27.1M | $17.1M | −$575.7M+4353% | −$1.8M | $32.1M+18% | $35.1M+105% | $43.7M |
| −$1.98 | −$0.96 | $0.01 | $1.98 | $1.31 | −$13.10+1265% | −$0.02 | $0.40−80% | $0.41−69% | $0.52 | |
| 13.4M | 13.5M | 16.6M | 13.7M | 92.7M+593% | 43.9M+225% | 78.9M+376% | 79.5M+481% | 82.4M−11% | 83.4M+90% |
Revenue: Q1 FY24 and Q1 FY25: 6 months less the 3 months printed beside them.
Cost of revenue: Q1 FY24 and Q1 FY25: 6 months less the 3 months printed beside them.
Gross profit: Q1 FY24 and Q1 FY25: 6 months less the 3 months printed beside them.
R&D: Q1 FY24: 6 months less the 3 months printed beside them.
SG&A: Q1 FY24 and Q1 FY25: 6 months less the 3 months printed beside them.
Operating income: Q1 FY24: 6 months less the 3 months printed beside them.
Pre-tax income: Q1 FY24 and Q1 FY25: 6 months less the 3 months printed beside them.
Income tax: Q1 FY24 and Q1 FY25: 6 months less the 3 months printed beside them.
Net income: Q1 FY24 and Q1 FY25: 6 months less the 3 months printed beside them.
EPS, diluted: 3 periods, Q1 FY24 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q1 FY24: share-days: the 6-month average less the second quarter's. Q4 FY24 and Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Software - Application nearest Hinge Health's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| HNGEHinge Health | $9.3B | 88.2× | 72.7× | n/m | 12.9× | +50% | 15.1% |
| ESTCElastic | $9.4B | 25.3× | 137× | n/m | 5.2× | +16% | 20.8% |
| MTCHMatch | $9.7B | 14.9× | 15.3× | n/m | 2.8× | +2% | 20.2% |
| DOCNDigitalOcean | $10.6B | 41.2× | 45.0× | n/m | 10.4× | +21% | 23.3% |
| PINSPinterest | $11.5B | 59.7× | 62.9× | n/m | 2.5× | +17% | 5.5% |
| HUBSHubSpot | $11.3B | 80.8× | 105× | n/m | 3.3× | +21% | 4.3% |
| FDSFactset Research Systems | $12.2B | 22.7× | 32.5× | n/m | 5.0× | +7% | 23.2% |
| RNGRingCentral | $6.5B | 61.8× | 69.8× | n/m | 2.5× | +5% | 4.3% |
| TTDTrade Desk | $5.9B | 14.9× | 123× | n/m | 2.0× | +12% | 13.6% |
| PEGAPegasystems | $5.7B | 19.5× | 66.5× | n/m | 3.3× | +4% | 18.7% |
| FICOFair Isaac | $15.3B | 20.5× | 50.7× | 14.6× | 6.4× | +24% | 34.1% |
| Peer median | $10.1B | 24.0× | 64.7× | 14.6× | 3.3× | +14% | 19.4% |
Investors who own it
Investors we follow who held Hinge Health at the end of Jun 30, 2026, from their 13F filings.
- Ron BaronBaron Capital0.1% of portfoliotrimmed
More on Hinge Health
Each number over time
Where it ranks
Its groups
About
- Industry
- Software - Application
- Sector
- Technology
Valuation data, not investment advice. Prices as of .